Preferred Label : Pluvicto;

CISMeF synonym : 177Lu-PSMA-617;

MeSH synonym : 177Lu-617-prostate-specific membrane antigen ligand; 177Lu-PSMA-617; ((177)Lu)Lu-PSMA-617; PSMA-617 Lu-177; Vipivotide tetraxetan Lu-177;

Details


Main resources

You can consult :


https://ansm.sante.fr/tableau-atu-rtu/177lu-lu-psma-617-solution-injectable-pour-perfusion
2023
false
false
false
France
French
Lutetium Lu 177 Vipivotide Tetraxetan
Pluvicto
drug information
lutetium (177Lu) vipivotide tetraxetan

---
https://www.has-sante.fr/jcms/p_3358995/fr/-177lu-lu-psma-617-cancer-de-la-prostate
https://www.has-sante.fr/jcms/p_3359005/fr/decision-n2022-0249/dc/sem-du-13-juillet-2022-du-college-de-la-haute-autorite-de-sante-portant-autorisation-d-acces-precoce-de-la-specialite-177lu-lu-psma-617-1000-mbq/ml-solution-injectable/pour-perfusion
2022
false
false
false
France
treatment outcome
insurance, health, reimbursement
adult
PSMA-Positive Tumor
Metastatic Prostate Carcinoma
guidelines for drug use
evaluation of the transparency committee
prostatic neoplasms, Castration-Resistant
Pluvicto

---
https://www.cadth.ca/fr/vipivotide-tetraxetan-marque-au-lutetium
2022
false
false
false
Canada
French
drug evaluation
Lutetium Lu 177 Vipivotide Tetraxetan
prostatic neoplasms, Castration-Resistant
neoplasm metastasis
FOLH1 protein, human
PSMA-Positive Tumor
lutetium (177Lu) vipivotide tetraxetan
Pluvicto

---
Nous contacter.
02/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.